JP2002526028A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526028A5
JP2002526028A5 JP2000517077A JP2000517077A JP2002526028A5 JP 2002526028 A5 JP2002526028 A5 JP 2002526028A5 JP 2000517077 A JP2000517077 A JP 2000517077A JP 2000517077 A JP2000517077 A JP 2000517077A JP 2002526028 A5 JP2002526028 A5 JP 2002526028A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
dna
seq
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000517077A
Other languages
English (en)
Japanese (ja)
Other versions
JP4319348B2 (ja
JP2002526028A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/021141 external-priority patent/WO1999020756A2/en
Publication of JP2002526028A publication Critical patent/JP2002526028A/ja
Publication of JP2002526028A5 publication Critical patent/JP2002526028A5/ja
Application granted granted Critical
Publication of JP4319348B2 publication Critical patent/JP4319348B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000517077A 1997-10-17 1998-10-07 ヒトトール相同体 Expired - Lifetime JP4319348B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US6225097P 1997-10-17 1997-10-17
US60/062,250 1997-10-17
US6531197P 1997-11-13 1997-11-13
US60/065,311 1997-11-13
US8332298P 1998-04-28 1998-04-28
US60/083,322 1998-04-28
US10541398A 1998-06-26 1998-06-26
US9086398P 1998-06-26 1998-06-26
US60/090,863 1998-06-26
US09/105,413 1998-06-26
PCT/US1998/021141 WO1999020756A2 (en) 1997-10-17 1998-10-07 Human toll homologues

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008328570A Division JP5027105B2 (ja) 1997-10-17 2008-12-24 ヒトトール相同体

Publications (3)

Publication Number Publication Date
JP2002526028A JP2002526028A (ja) 2002-08-20
JP2002526028A5 true JP2002526028A5 (enExample) 2006-02-16
JP4319348B2 JP4319348B2 (ja) 2009-08-26

Family

ID=27535565

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000517077A Expired - Lifetime JP4319348B2 (ja) 1997-10-17 1998-10-07 ヒトトール相同体
JP2008328570A Expired - Lifetime JP5027105B2 (ja) 1997-10-17 2008-12-24 ヒトトール相同体
JP2012017737A Expired - Lifetime JP5425244B2 (ja) 1997-10-17 2012-01-31 ヒトトール相同体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2008328570A Expired - Lifetime JP5027105B2 (ja) 1997-10-17 2008-12-24 ヒトトール相同体
JP2012017737A Expired - Lifetime JP5425244B2 (ja) 1997-10-17 2012-01-31 ヒトトール相同体

Country Status (11)

Country Link
EP (3) EP1650219B1 (enExample)
JP (3) JP4319348B2 (enExample)
AT (3) ATE314471T1 (enExample)
AU (1) AU1070399A (enExample)
CA (1) CA2305385C (enExample)
DE (3) DE69838888T2 (enExample)
DK (3) DK1650219T3 (enExample)
ES (2) ES2343210T3 (enExample)
IL (4) IL135345A0 (enExample)
PT (2) PT1650219E (enExample)
WO (1) WO1999020756A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696327B1 (en) 1997-10-17 2010-04-13 Genentech, Inc. Antibodies to human Toll homologues
ATE348157T1 (de) * 1997-05-07 2007-01-15 Schering Corp Menschliche toll-ähnliche rezeptorproteine, zugehörige reagenzien und verfahren
AU2001264889B2 (en) * 1997-05-07 2006-06-29 Schering Corporation Human receptor proteins; related reagents and methods
US20030032090A1 (en) 1997-05-07 2003-02-13 Schering Corporation, A New Jersey Corporation Human receptor proteins; related reagents and methods
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
JP2003533996A (ja) * 2000-05-25 2003-11-18 シェーリング コーポレイション ヒトレセプタータンパク質、関連試薬および方法
US6943240B2 (en) 2000-09-15 2005-09-13 Coley Pharmaceuticals Gmbh Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
EP1293566A1 (en) * 2001-09-17 2003-03-19 Societe Des Produits Nestle S.A. A soluble toll-like receptor
EP2366389A1 (en) * 2002-04-08 2011-09-21 Takeda Pharmaceutical Company Limited Severe sepsis preventive therapeutic agent
EP2301564A1 (en) 2002-05-04 2011-03-30 Acorda Therapeutics, Inc. Compositions and methods for promoting neuronal outgrowth
CA2505843A1 (en) 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
CA2506356A1 (en) * 2002-11-22 2004-06-10 Nuvelo, Inc. Methods of therapy and diagnosis
WO2004094671A2 (en) * 2003-04-22 2004-11-04 Coley Pharmaceutical Gmbh Methods and products for identification and assessment of tlr ligands
US7959914B2 (en) 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
AU2004247026B2 (en) * 2003-05-16 2009-09-24 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of CNS
US7696169B2 (en) 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
JP4562123B2 (ja) * 2003-06-17 2010-10-13 明治乳業株式会社 Ｔｏｌｌ様レセプター強制発現細胞の利用
WO2005001116A1 (ja) * 2003-06-17 2005-01-06 Meiji Dairies Corporation Toll様レセプター強制発現細胞の利用
AU2004272607B2 (en) 2003-09-11 2008-11-06 Cornerstone Therapeutics Inc. Monoclonal antibodies against HMGB1
ES2411504T3 (es) 2004-05-18 2013-07-05 Acorda Therapeutics, Inc. Métodos de purificación de condroitinasa y formulaciones estables de la misma
NZ550772A (en) * 2004-05-21 2009-10-30 Uab Research Foundation Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
EP1869463A4 (en) 2005-04-15 2010-05-05 Becton Dickinson Co SEPSIS DIAGNOSIS
CA2623635C (en) 2005-09-26 2013-04-02 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase abci mutants
WO2007051164A2 (en) 2005-10-27 2007-05-03 Centocor, Inc. Toll like receptor 3 modulators, methods and uses
WO2008036437A2 (en) * 2006-04-19 2008-03-27 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
CA3086902C (en) 2006-10-10 2021-11-09 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase abci mutants
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
SI2528598T1 (sl) 2010-01-27 2016-04-29 Takeda Pharmaceutical Company Limited Spojine za supresijo periferne živčne motnje, inducirane s sredstvom proti raku
CN117534753B (zh) * 2023-12-07 2024-05-10 北京博奥森生物技术有限公司 一种诱导高性能NF-κB多克隆抗体多肽及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
DE3850542T2 (de) 1987-09-23 1994-11-24 Bristol Myers Squibb Co Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
AU641673B2 (en) 1989-06-29 1993-09-30 Medarex, Inc. Bispecific reagents for aids therapy
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
CA2089661C (en) 1990-08-29 2007-04-03 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
JPH06507398A (ja) 1991-05-14 1994-08-25 リプリジェン　コーポレーション Ｈｉｖ感染治療のための異種複合抗体
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
ATE348157T1 (de) * 1997-05-07 2007-01-15 Schering Corp Menschliche toll-ähnliche rezeptorproteine, zugehörige reagenzien und verfahren
DE69931284T9 (de) * 1998-03-25 2007-10-18 Genentech Inc., San Francisco Menschliches Neurotrimin-Homolog

Similar Documents

Publication Publication Date Title
JP2002526028A5 (enExample)
AU738688B2 (en) Cysteine rich receptors-train
US8435494B2 (en) Mesothelin antibody protein fusions and methods of use
EP0617706B1 (en) Multivalent antigen-binding proteins
CA2309783A1 (en) Fibroblast growth factor-19
WO2005090405A1 (ja) インターロイキン－６受容体に対するヒト型化抗体のサブタイプ
CA2505705A1 (en) Compositions and methods for the diagnosis and treatment of tumor
CA2225189A1 (en) Canine factor viii gene, protein and methods of use
AU655586B2 (en) Monoclonal antibodies specific for toxin B of clostridium difficile
JP2002500043A5 (enExample)
JP2003534013A5 (enExample)
KR20140135766A (ko) 종양괴사인자 수용체 융합 단백질 및 이를 이용하는 방법
IL145676A (en) Tumor necrosis factor homologs and nucleic acids encoding the same
JP2005518212A5 (enExample)
KR970070198A (ko) 항-파스 재조합 항체 및 이에 대한 디엔아이
CN116419928A (zh) Fcα受体结合抗体
JP2006311824A (ja) 豚マイコプラズマ肺炎ワクチン
US6790937B2 (en) Recombinant scFV antibodies specific to Eimeria spp. responsible for coccidiosis
US20090214547A1 (en) Binding member towards pneumolysin
EP1304375A1 (en) Method of preparing antibody by gene immunization
CA2271774A1 (en) Helicobacter polypeptides and corresponding polynucleotide molecules
WO1992012173A1 (en) A method for constructing antigens
JP2002051785A (ja) 抗癌ヒトモノクローナル抗体ＣＬＮ−ＩｇＧによって認識される抗原エピトープのアミノ酸配列およびそれをコードするＤＮＡヌクレオチド配列
TH68879B (th) โมเลกุลของสายพันธุ์กลายของ ctla4 ที่ละลายได้ และการใช้โมเลกุลเหล่านี้
TH70422A (th) โมเลกุลของสายพันธุ์กลายของ ctla4 ที่ละลายได้ และการใช้โมเลกุลเหล่านี้